MedPath

FULVESTRANT

Fulvestrant Injection

Approved
Approval ID

151b948a-3106-497a-b1c7-479307faeb89

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 26, 2022

Manufacturers
FDA

Zydus Lifesciences Limited

DUNS: 918596198

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

fulvestrant

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70771-1626
Application NumberANDA215234
Product Classification
M
Marketing Category
C73584
G
Generic Name
fulvestrant
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateAugust 26, 2022
FDA Product Classification

INGREDIENTS (5)

ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
BENZYL BENZOATEInactive
Code: N863NB338G
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
CASTOR OILInactive
Code: D5340Y2I9G
Classification: IACT
FULVESTRANTActive
Quantity: 50 mg in 1 mL
Code: 22X328QOC4
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.